318 related articles for article (PubMed ID: 24827035)
21. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.
Wang JL; Yang X; Xia K; Hu ZM; Weng L; Jin X; Jiang H; Zhang P; Shen L; Guo JF; Li N; Li YR; Lei LF; Zhou J; Du J; Zhou YF; Pan Q; Wang J; Wang J; Li RQ; Tang BS
Brain; 2010 Dec; 133(Pt 12):3510-8. PubMed ID: 21106500
[TBL] [Abstract][Full Text] [Related]
22. Rare nonconservative LRP6 mutations are associated with metabolic syndrome.
Singh R; Smith E; Fathzadeh M; Liu W; Go GW; Subrahmanyan L; Faramarzi S; McKenna W; Mani A
Hum Mutat; 2013 Sep; 34(9):1221-5. PubMed ID: 23703864
[TBL] [Abstract][Full Text] [Related]
23. Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B.
Papenfuss M; Lützow S; Wilms G; Babendreyer A; Flaßhoff M; Kunick C; Becker W
Sci Rep; 2022 Feb; 12(1):2393. PubMed ID: 35165364
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus.
Li JK; Ng MC; So WY; Chiu CK; Ozaki R; Tong PC; Cockram CS; Chan JC
Diabetes Metab Res Rev; 2006; 22(1):46-52. PubMed ID: 16021651
[TBL] [Abstract][Full Text] [Related]
25. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
[TBL] [Abstract][Full Text] [Related]
26. Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes.
Yaghootkar H; Scott RA; White CC; Zhang W; Speliotes E; Munroe PB; Ehret GB; Bis JC; Fox CS; Walker M; Borecki IB; Knowles JW; Yerges-Armstrong L; Ohlsson C; Perry JR; Chambers JC; Kooner JS; Franceschini N; Langenberg C; Hivert MF; Dastani Z; Richards JB; Semple RK; Frayling TM
Diabetes; 2014 Dec; 63(12):4369-77. PubMed ID: 25048195
[TBL] [Abstract][Full Text] [Related]
27. DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.
Singh R; Dhanyamraju PK; Lauth M
Oncotarget; 2017 Jan; 8(1):833-845. PubMed ID: 27903983
[TBL] [Abstract][Full Text] [Related]
28. Developmental dysplasia of the hip: linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family.
Feldman GJ; Parvizi J; Levenstien M; Scott K; Erickson JA; Fortina P; Devoto M; Peters CL
J Bone Miner Res; 2013 Dec; 28(12):2540-9. PubMed ID: 23716478
[TBL] [Abstract][Full Text] [Related]
29. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice.
Bhat N; Narayanan A; Fathzadeh M; Kahn M; Zhang D; Goedeke L; Neogi A; Cardone RL; Kibbey RG; Fernandez-Hernando C; Ginsberg HN; Jain D; Shulman GI; Mani A
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34855620
[TBL] [Abstract][Full Text] [Related]
30. MODY type 2 P59S GCK mutant: founder effect in South of Italy.
Delvecchio M; Ludovico O; Bellacchio E; Stallone R; Palladino T; Mastroianno S; Zelante L; Sacco M; Trischitta V; Carella M
Clin Genet; 2013 Jan; 83(1):83-7. PubMed ID: 22335469
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.
Boczek NJ; Best JM; Tester DJ; Giudicessi JR; Middha S; Evans JM; Kamp TJ; Ackerman MJ
Circ Cardiovasc Genet; 2013 Jun; 6(3):279-89. PubMed ID: 23677916
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases.
Leder S; Weber Y; Altafaj X; Estivill X; Joost HG; Becker W
Biochem Biophys Res Commun; 1999 Jan; 254(2):474-9. PubMed ID: 9918863
[TBL] [Abstract][Full Text] [Related]
33. Common founder effects of hereditary hemochromatosis, Wilson´s disease, the long QT syndrome and autosomal recessive deafness caused by two novel mutations in the
Olsson KS; Wålinder O; Jansson U; Wilbe M; Bondeson ML; Stattin EL; Raha-Chowdhury R; Williams R
Hereditas; 2017; 154():16. PubMed ID: 29270100
[TBL] [Abstract][Full Text] [Related]
34. DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.
Yousefelahiyeh M; Xu J; Alvarado E; Yu Y; Salven D; Nissen RM
PLoS One; 2018; 13(11):e0207779. PubMed ID: 30496304
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.
Folon L; Baron M; Scherrer V; Toussaint B; Vaillant E; Loiselle H; Dechaume A; De Pooter F; Boutry R; Boissel M; Diallo A; Ning L; Balkau B; Charpentier G; Franc S; Marre M; Derhourhi M; Froguel P; Bonnefond A
Diabetes Care; 2024 Mar; 47(3):444-451. PubMed ID: 38170957
[TBL] [Abstract][Full Text] [Related]
36. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
37. TSC22D2 identified as a candidate susceptibility gene of multi-cancer pedigree using genome-wide linkage analysis and whole-exome sequencing.
Xiao L; Wei F; Liang F; Li Q; Deng H; Tan S; Chen S; Xiong F; Guo C; Liao Q; Li X; Zhang W; Wu M; Zhou Y; Xiang B; Zhou M; Li X; Xiong W; Zeng Z; Li G
Carcinogenesis; 2019 Jul; 40(7):819-827. PubMed ID: 31125406
[TBL] [Abstract][Full Text] [Related]
38. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes.
Tanaka D; Nagashima K; Sasaki M; Funakoshi S; Kondo Y; Yasuda K; Koizumi A; Inagaki N
Mol Genet Metab; 2013 May; 109(1):112-7. PubMed ID: 23499280
[TBL] [Abstract][Full Text] [Related]
39. DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS.
Lauth M; Bergström A; Shimokawa T; Tostar U; Jin Q; Fendrich V; Guerra C; Barbacid M; Toftgård R
Nat Struct Mol Biol; 2010 Jun; 17(6):718-25. PubMed ID: 20512148
[TBL] [Abstract][Full Text] [Related]
40. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
